Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

18.221.200.48
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-
Journal Scan
Oncology

Persistent radiation-induced alopecia dose-dependent in sarcoma

Posted on

In patients with primary central nervous system (CNS) tumors or head and neck sarcoma who had persistent radiation-induced alopecia, topical minoxidil and procedural interventions may be beneficial, according to a study in JAMA Dermatology.

In this retrospective cohort study, 71 patients with primary CNS tumors or head and neck sarcomas who were evaluated for persistent radiation-induced alopecia, were included.

-Advertisement-
-Advertisement-

In 56% of patients, alopecia severity was grade 1, with 54% localized, 24% diffuse, or 22% mixed patterns.

The median (range) estimated scalp radiation dose was 39.6 GY and higher dose and proton irradiation was associated with more severe alopecia. At a dose of 36.1 Gy, 50% of patients were estimated to have grade 2 or higher alopecia.

In total, 82% of patients responded to topical minoxidil, with 5% experiencing clinical images improved in severity grade.

Reference
Phillips GS, Freret ME, Friedman DN, et al. Assessment and treatment outcomes of persistent radiation-induced alopecia in patients with cancer. JAMA Dermatol. Published online August 05, 2020. doi:10.1001/jamadermatol.2020.2127

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-